Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sinopharm to Acquire 80% of Aurobindo’s China Subsidiary

publication date: Jan 11, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China National Pharmaceutical Group Corporation (Sinopharm) will purchase 80% of an Aurobindo Pharma subsidiary in China. Aurobindo is an Indian generic pharmaceutical company, and its China subsidiary makes 6-APA, a derivative of Penicillin-G that Aurobindo uses for its own antibiotic products, which are manufactured in India. More details....

Stock Symbol: (SH: 600511)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners